MeSH tree: D12.776.124.125.350
Researchers from the Centenary Institute have uncovered a reason why some people with hemophilia A develop resistance to their critical treatment, paving the way for the development of more effective therapies. The study ...
May 28, 2025
0
0
Cell and gene therapies harbor great hopes for biomedicine. They are becoming increasingly important for diseases that are currently difficult or impossible to treat—for example, aggressive forms of cancer or rare diseases ...
May 27, 2025
0
0
Research led by Christian Medical College in Vellore, India, has demonstrated the successful use of lentiviral vectors to deliver gene therapy for patients with severe hemophilia A. The study presents a potential alternative ...
Researchers at the Wake Forest Institute for Regenerative Medicine (WFIRM) have recently published an article in Nature Communications that demonstrates the potential of bioengineered human placental cells as a cure for Hemophilia ...
Nov 30, 2023
0
58
New research led by a St. Michael's Hospital scientist reveals how platelets can inhibit inflammation and immune responses. The discovery, published in the journal Research, constitutes a fundamental re-understanding of platelets ...
Oct 6, 2023
0
46
The U.S. Food and Drug Administration on Thursday approved a costly single-dose gene therapy for patients with severe hemophilia A, a life-threatening hereditary bleeding disorder.
Jul 3, 2023
0
1
In hemophilia A cases, the body either partially or completely lacks the blood coagulation factor VIII (FVIII), or the factor is formed incorrectly. Patients usually receive FVIII that comes from donor blood or is produced ...
Feb 7, 2023
0
3
A global study involving McMaster University researchers has trialed a potential new treatment that could be a game-changer for people living with hemophilia A, a life-threatening genetic blood disorder.
Jan 26, 2023
0
3
Immune responses against Factor VIII, which is used to treat hemophilia A (bleeding disorder), are influenced by the microenvironment of antigen presenting cells. This is the result of a scientific study conducted in cooperation ...
Nov 22, 2022
0
14
Hemophilia A is the most common severe form of hemophilia. It almost exclusively affects males. The disease can usually be treated well, but not for all sufferers. A study at the University of Bonn has now elucidated an important ...
Oct 26, 2022
0
25
